No association between a candidate TCF7L2 variant and risk of breast or ovarian cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
No association between a candidate TCF7L2 variant and risk of breast or ovarian cancer ; volume:9 ; number:1 ; day:4 ; month:9 ; year:2009 ; pages:1-4 ; date:12.2009
BMC cancer ; 9, Heft 1 (4.9.2009), 1-4, 12.2009
- Creator
-
Goode, Ellen L.
- Contributor
-
Szabó, Csilla
Prokunina-Olsson, Ludmila
Vierkant, Robert A.
Fredericksen, Zachary S.
Collins, Francis S.
White, Kristin L.
Schmidt, Michele
Fridley, Brooke L.
Couch, Fergus J.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-9-312
- URN
-
urn:nbn:de:1111-2016030353881
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:19 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Goode, Ellen L.
- Szabó, Csilla
- Prokunina-Olsson, Ludmila
- Vierkant, Robert A.
- Fredericksen, Zachary S.
- Collins, Francis S.
- White, Kristin L.
- Schmidt, Michele
- Fridley, Brooke L.
- Couch, Fergus J.
- SpringerLink (Online service)
Other Objects (12)
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing
The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk
Advocate-BREAST: advocates and patients’ advice to enhance breast cancer care delivery, patient experience and patient centered research by 2025
Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework
Alcohol consumption and breast tumor gene expression
Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer
The influence of mammogram acquisition on the mammographic density and breast cancer association in the mayo mammography health study cohort
A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene
Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing
The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk
Advocate-BREAST: advocates and patients’ advice to enhance breast cancer care delivery, patient experience and patient centered research by 2025
Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework
Alcohol consumption and breast tumor gene expression
Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer
The influence of mammogram acquisition on the mammographic density and breast cancer association in the mayo mammography health study cohort
A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene
Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing
The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk
Advocate-BREAST: advocates and patients’ advice to enhance breast cancer care delivery, patient experience and patient centered research by 2025
Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework
Alcohol consumption and breast tumor gene expression
Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer
The influence of mammogram acquisition on the mammographic density and breast cancer association in the mayo mammography health study cohort
A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene